Advertisement
Singapore markets close in 6 hours 35 minutes
  • Straits Times Index

    3,499.73
    +1.95 (+0.06%)
     
  • Nikkei

    41,190.68
    -1,033.32 (-2.45%)
     
  • Hang Seng

    18,146.86
    -146.52 (-0.80%)
     
  • FTSE 100

    8,252.91
    +29.57 (+0.36%)
     
  • Bitcoin USD

    61,547.21
    +2,007.54 (+3.37%)
     
  • CMC Crypto 200

    1,281.00
    +82.43 (+6.89%)
     
  • S&P 500

    5,615.35
    +30.81 (+0.55%)
     
  • Dow

    40,000.90
    +247.10 (+0.62%)
     
  • Nasdaq

    18,398.45
    +115.04 (+0.63%)
     
  • Gold

    2,415.30
    -5.40 (-0.22%)
     
  • Crude Oil

    82.27
    +0.06 (+0.07%)
     
  • 10-Yr Bond

    4.1890
    -0.0040 (-0.10%)
     
  • FTSE Bursa Malaysia

    1,623.99
    +4.93 (+0.30%)
     
  • Jakarta Composite Index

    7,318.94
    -8.64 (-0.12%)
     
  • PSE Index

    6,708.32
    +60.09 (+0.90%)
     

Swedish Exchange Growth Companies With At Least 12% Insider Ownership

As global markets experience fluctuations, with some indices reaching new highs and others showing modest declines, investors are keenly observing trends and shifts. In this context, growth companies in Sweden with high insider ownership present a unique appeal, as such stakes can signal confidence in the company's future from those who know it best.

Top 10 Growth Companies With High Insider Ownership In Sweden

Name

Insider Ownership

Earnings Growth

CTT Systems (OM:CTT)

16.9%

21.6%

Spago Nanomedical (OM:SPAGO)

16.1%

52.1%

BioArctic (OM:BIOA B)

35.1%

63%

Calliditas Therapeutics (OM:CALTX)

11.6%

49.9%

Sileon (OM:SILEON)

33.3%

109.3%

InCoax Networks (OM:INCOAX)

18.9%

104.9%

KebNi (OM:KEBNI B)

37.8%

90.4%

Egetis Therapeutics (OM:EGTX)

17.6%

98.2%

Yubico (OM:YUBICO)

37.5%

43%

SaveLend Group (OM:YIELD)

24.8%

106.8%

Click here to see the full list of 85 stocks from our Fast Growing Swedish Companies With High Insider Ownership screener.

ADVERTISEMENT

Let's review some notable picks from our screened stocks.

Pandox

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Pandox AB, a Swedish hotel property company, focuses on owning, operating, and leasing hotel properties with a market capitalization of approximately SEK 33.50 billion.

Operations: The company generates revenue primarily through two segments: own operation, which brought in SEK 3.24 billion, and rental agreements, contributing SEK 3.76 billion.

Insider Ownership: 12.3%

Pandox AB, a Swedish hotel operator, has shown robust earnings growth with forecasts indicating a 46.3% annual increase, outpacing the broader Swedish market significantly. Despite this positive outlook, challenges persist; the company’s profit margins have declined sharply from last year and its dividend coverage remains weak due to earnings not sufficiently covering interest payments. Recent financial reports highlight a strong rebound with substantial increases in sales and net income compared to previous losses, reflecting potential resilience and recovery in operations.

OM:PNDX B Ownership Breakdown as at May 2024
OM:PNDX B Ownership Breakdown as at May 2024

RaySearch Laboratories

Simply Wall St Growth Rating: ★★★★☆☆

Overview: RaySearch Laboratories AB, a medical technology company, develops software solutions for cancer care across various global regions and has a market capitalization of approximately SEK 5.01 billion.

Operations: The company generates its revenue by providing software solutions for cancer care across diverse global regions including the Americas, Europe, Africa, Asia-Pacific, and the Middle East.

Insider Ownership: 24.1%

RaySearch Laboratories, a Swedish medical technology firm, has demonstrated significant insider ownership stability and growth potential. Recently, the company reported a strong earnings increase with net income more than doubling in the first quarter of 2024. This performance is coupled with strategic alliances, such as with C-RAD to enhance radiation therapy quality. However, its revenue growth forecast at 10.5% annually trails behind faster-growing peers but outpaces the broader Swedish market's 2.1% expected rate.

OM:RAY B Ownership Breakdown as at May 2024
OM:RAY B Ownership Breakdown as at May 2024

Surgical Science Sweden

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Surgical Science Sweden AB operates globally, developing and marketing virtual reality simulators for evidence-based medical training, with a market capitalization of approximately SEK 7.36 billion.

Operations: The company generates its revenue from the development and sale of virtual reality simulators for medical training across Europe, North and South America, and Asia.

Insider Ownership: 26.6%

Surgical Science Sweden, a key player in medical simulation, is trading at 58.5% below its estimated fair value, suggesting potential undervaluation. The company's earnings are projected to grow by 26.67% annually, outpacing the Swedish market's forecast of 14.3%. Despite this growth, its expected Return on Equity of 6.3% is considered low. Recent leadership changes with CEO Gisli Hennermark planning to step down could signal a pivotal moment for strategic direction and investor relations.

OM:SUS Ownership Breakdown as at May 2024
OM:SUS Ownership Breakdown as at May 2024

Taking Advantage

Looking For Alternative Opportunities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include OM:PNDX BOM:RAY B

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com